Hamilton Point Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-25,299
Closed -$1.91M 72
2018
Q1
$1.91M Buy
25,299
+3,031
+14% +$241K 0.97% 47
2017
Q4
$1.59M Sell
22,268
-803
-3% -$61K 0.83% 52
2017
Q3
$1.87M Buy
23,071
+50
+0.2% +$3.82K 1.01% 44
2017
Q2
$1.63M Buy
23,021
+69
+0.3% +$4.59K 0.91% 48
2017
Q1
$1.56M Buy
22,952
+1,840
+9% +$129K 0.89% 52
2016
Q4
$1.51M Sell
21,112
-1,812
-8% -$135K 0.93% 52
2016
Q3
$1.81M Buy
22,924
+107
+0.5% +$8.69K 1.14% 46
2016
Q2
$1.9M Buy
22,817
+95
+0.4% +$8.43K 1.24% 38
2016
Q1
$2.09M Sell
22,722
-130
-0.6% -$11.7K 1.39% 32
2015
Q4
$2.31M Buy
22,852
+1,615
+8% +$168K 1.6% 27
2015
Q3
$2.08M Buy
21,237
+1,847
+10% +$205K 1.63% 24
2015
Q2
$2.27M Buy
+19,390
New +$2.12M 1.84% 22

Other funds holding GILD

Hamilton Point Investment Advisors's GILD Position: Q2 2018 in Review

Hamilton Point Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 25,299 shares — an estimated $1.91M sold.

Hamilton Point Investment Advisors first reported a position in GILD in Q2 2015 and held it in 12 quarters. The position peaked at $2.31M in Q4 2015. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Hamilton Point Investment Advisors reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Hamilton Point Investment Advisors sold 25,299 Gilead Sciences shares in Q2 2018, an estimated $1.91M.
  • Hamilton Point Investment Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 12 quarters.
  • Hamilton Point Investment Advisors's Gilead Sciences position peaked at $2.31M in Q4 2015.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2018, filed 18 Jul 2018.